|
Sensex ends 100 points up, Nifty below 8,500; Sun Pharma top gainer, up 4% Snapping a two-day losing streak, the S&P BSE Sensex rose 100 points, or 0.36 per cent, to settle the day at 27931.64... |
Amtek Auto cracks 40%; NSE to exclude stock from F&O segment The sentiment was negative since NSE said it will exclude the stock from its futures and options segment effective Oc... |
Midcap valuations beat largecaps'; 10 stocks that fell up to 80% in 1 year Small caps have outperformed in July, while on a calendar year basis, the mid cap index has shown a strong out perfor... |
|
|
|
|
FROM THE NEWSPAPER |
Majesco makes decent debut, climbs 5% over listing price; Mastek falls 5% Majesco, the demerged arm of Mastek, made a decent debut on the NSE, surging 5 per cent to settle at Rs 331.80.... |
Cipla makes it to HSBC's GEMs Super 15 portfolio; 'expect 17% upside' They have added Cipla to their GEMs Super 15 portfolio list. It ranks in the top 50 EM companies that are most defens... |
China devalues yuan: A threat or an opportunity for Indian markets? China's surprise move last week to weaken the yuan by about 2 per cent stirred equity as well as currency markets glo... |
Timing gold is a fool's errand; it is not correlated to the stock market Investors may consider underpinnings of prior bull run of over 400% that started when Nixon took the dollar off the g... |
Strong macros keep rupee out of the 'troubled ten' currencies After the yuan devaluation, the rupee is not in the basket of 'troubled ten" currencies – a new term coined for units... |
MORE LINKS:Gainers|Losers|Movers|Only Buyers|Only Sellers|Surging Volumes|Indices |
|
More Newsletters |
|
| | ET Mutual Fund A weekly round-up of the top news and views from the mutual fund industry. | | | | | Wealth Weekly news on personal finance, stocks, property, gold, tax planning and more. | | | |
|
|
To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here |
To unsubscribe or edit your subscriptions please click here |
0 comments:
Speak up your mind
Tell us what you're thinking... !